Immunogenicity and Safety of ChAdOx1 nCoV-19 (AZD1222) as a Homologous Fourth-Dose Booster: A Substudy of the Phase 3 COV003 Trial in Brazil

Costa Clemens SA., Bibi S., Marchevsky NG., Aley PK., Cappuccini F., Davies SA., Gonzalez I., Kelly SC., Mujadidi YF., Pipolo Milan E., Schwarzbold AV., Sprinz E., Voysey M., Weckx LY., Wright D., Bansal H., Bergagård MAS., Isaacs AJ., Kelly EJ., Lan D., Morgan S., Shankar NK., Shoemaker K., Villafana TL., Lambe T., Green JA., Pollard AJ.

DOI

10.1016/j.mayocpiqo.2025.100642

Type

Journal article

Publisher

Elsevier BV

Publication Date

2025-08-01T00:00:00+00:00

Volume

9

Pages

100642 - 100642

Total pages

0

Permalink More information Close